🧵 3-Monoiodothyronamine (T1AM): the rationale for its action as an endogenous adrenergic-blocking neuromodulator Heinrich Gompf, Joel Greenberg, Gary Aston-Jones, Alexandra Ianculescu, Tom Scanlan, Mary Dratman Brain Research 2010 Sep 10; 1351: 130-140…
3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulator By Heinrich Gompf, Joel Greenberg, Gary Aston-Jones @GaryAstonJones, Alexandra Ianculescu, Tom Scanlan @ScanlanLab, & Mary Dratman Brain Resear…
T1AM derived from reverse T3, while functional studies provided well-confirmed evidence that T1AM has strong adrenergic blocking effects https://t.co/QfugowFRcX
heb trouwens aan m'n ondev. meneer gevraagd of propranolol iets uit zou maken http://t.co/k5FGQarj #beterlaatdannooithe